期刊文献+

通过FasL通路阻抑肿瘤免疫逃逸的研究 被引量:1

Study on Blocking the Tumor Immune Escape by Fas Ligand Pathway
暂未订购
导出
摘要 许多白血病和实体瘤细胞通过高表达Fas配体 (FasL)而发生肿瘤的免疫逃逸。为了观察腺病毒载体向肿瘤细胞导入小鼠可溶性Fas(sFas)基因后能否阻抑肿瘤细胞通过FasL发生肿瘤免疫逃逸作用 ,采用AdEasy腺病毒载体系统 ,利用大肠杆菌内质粒间同源重组的方法分别构建携带小鼠sFas基因及增强型绿色荧光蛋白 (EGFP)的重组腺病毒载体 ,扩增纯化后利用空斑试验测定滴度 ,Westernblot检测蛋白的表达。然后 ,分别感染肿瘤细胞 EL4细胞 ,用氚胸腺嘧啶核苷 ( 3 H thymidine,3 H TdR)掺入法检测其诱导靶细胞YAC 1的凋亡率。结果表明 ,获得了重组成功的复制缺陷的腺病毒载体AdsFas和AdEGFP ,密度梯度离心纯化后其滴度达到 10 11pfu/ml,Westernblot分析证实前者能够高效表达出sFas蛋白。转染肿瘤细胞EL4细胞之后与YAC 1细胞混合培养 ,导入sFas组的YAC 1凋亡率在效靶比 (E∶T)为 3∶1,10∶1和 30∶1时分别为 6 %、7%和 9% ,与对照组 (分别为 2 8%、37%和4 5 % )相比明显下降 ,统计学有显著性差异 (P <0 .0 1) ;而导入EGFP组YAC 1凋亡率 (分别为 30 %、36 %和 4 8% )与对照组相似 ,没有统计学差异 (P >0 .0 5 )。结论 :腺病毒介导sFas的导入能够明显抑制肿瘤细胞EL4诱导Fas+细胞 YAC 1的凋亡 。 The expression of Fas ligand (FasL) on the membrane of many kinds of leukemia or solid tumor cells played an important role in the immune escape of tumor cells. This study was aimed to know if the soluble Fas (sFas), expressed by adenovirus, could block the immune escape of tumor cells by FasL pathway. The two recombinant adenoviral vectors, AdsFas with murine soluble Fas gene and AdEGFP with enhanced GFP protein gene, were constructed by homologous recombination between two plasmids in Escherichia coli with the AdEasy adenovirus vector system. The viruses were propagated and purified by two times ultracentrifugation. Their titres were detected by plaque assays. The expressed protein was evaluated by Western blot analysis. Then the tumor EL4 cells were infected with AdsFas and AdEGFP respectively. The apoptosis ratio of the target cells YAC 1 cells induced by EL4 cells was respectively detected by 3H thymidine ( 3H TdR) labeling. The results showed that the recombinant adenoviral vectors AdsFas and AdEGFP were successfully obtained. The titres of viruses purified by two times ultracentrifugation were up to 10 11 pfu/ml by plaque assays. The sFas protein was highly expressed in the target cells by Western blot analysis. After the EL4 cells were transfected with the adenoviruses AdsFas,the apoptosis rate of YAC 1 cells in the sFas transfection group (respectively 6%?7% and 9% when the effector∶target (E∶T) was 3∶1?10∶1 and 30∶1) was obviously lower than that in the control group(respectively 28%?37% and 45%), P<0.01. But when the EL4 cells were transfected with AdEGFP, the apoptosis rate of YAC 1 cells(respctively 30%?36% and 48%)was similar to the control group, P>0 05. In conclusion, the transfer of sFas by adenovirus could inhibit the apoptosis of Fas + cells YAC 1 cells induced by tumor EL4 cells. It showed that the transduction of sFas could block the effect of the immune escape of EL4 cells through FasL in vitro. These results thus provide a new direction to find a way to treat tumors.
出处 《中国实验血液学杂志》 CAS CSCD 2003年第6期616-621,共6页 Journal of Experimental Hematology
基金 国家自然科学基金资助项目 编号 3 9970 70 8
关键词 FAS配体 重组腺病毒 肿瘤 免疫逃逸 白血病 FASL 基因 免疫系统 Fas ligand recombinant adenovirus tumor immune escape leukemia
  • 相关文献

参考文献2

共引文献1

同被引文献22

  • 1Nisha Nagarkatti,Barbara A. Davis.Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand[J]. Cancer Chemotherapy and Pharmacology . 2003 (4)
  • 2Shyr-Ming Sheen-Chen,Han-Shiang Chen,Hock-Liew Eng,Wei-Jen Chen.Circulating Soluble Fas in Patients with Breast Cancer[J]. World Journal of Surgery . 2003 (1)
  • 3C. Herrnring,T. Reimer,U. Jeschke,J. Makovitzky,K. Krüger,B. Gerber,D. Kabelitz,K. Friese.Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors[J]. Histochemistry and Cell Biology . 2000 (3)
  • 4Lee SH,Shin MS,Park WS,et al.Alterations of Fas(Apo-1/ CD95) gene in non-small cell lung cancer. Oncegene . 1999
  • 5Owen Schaub L,Chan H,Cusack JC,et al.Fas and Fas ligand interactions in malignant disease. International Journal of Oncology . 2000
  • 6Leithauser F,Dhein J,Mechtersheimer G,et al.Constitutive and induced expression of Apo-1, a new member of the nerve growth factor/ tumor necrosis factor receptor super-family, in normal and neoplastic cells. Laboratory Investigation . 1993
  • 7Pitti RM,Marsters SA,Lawrence DA,et al.Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature . 1998
  • 8Ivanov VN,Bhoumik A,Krasilnikov M,et al.Cooperation between STAT3 and c-jun suppresses Fas transcription. Molecular Cell . 2001
  • 9Dearstyne EA,Kerkvliet NI.Mechanism of 2,3,7, Stetrachlorodi-benzo-p-dioxin(TCDD)-induced decrease in antiCD3activated CD4 + T cells: the roles of apoptosis, Fas, and TNF. Toxicology . 2002
  • 10Nagarkatti N,Davis BA.Tamoxifen induces apoptosis in Fas+ tumor cells by upregulating the expression of Fas ligand. Cancer Chemotherapy and Pharmacology . 2003

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部